
The Direxion Daily TSLA Bull 2X ETF and Direxion Daily TSLA Bear 1X ETF are designed to achieve particular daily returns based on the performance of Tesla, Inc. (NASDAQ: TSLA) common stock. The Bull 2X ETF targets daily investment outcomes that are double (200%) the stock's performance, before deducting fees and expenses. In contrast, the Bear 1X ETF strives for daily results equal to the inverse (or opposite) movement of Tesla's shares, prior to any associated costs.
Is TSLS's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.

Second-quarter earnings season is ramping up with the third week of July slated to bring some high-profile reports, including one from Elon Musk's Tesla, Inc. (TSLA). The electric vehicle giant is scheduled to deliver its latest batch of quarterly results on Wednesday, July 22, after the close of U.S. markets.

Direxion Daily TSLA Bear 1X Shares (NASDAQ: TSLS - Get Free Report) saw a large decrease in short interest in April. As of April 15th, there was short interest totaling 30,843 shares, a decrease of 43.3% from the March 31st total of 54,401 shares. Currently, 2.4% of the company's shares are sold short. Based on an

The sheer complexity of exchange-traded funds (ETFs) using derivative-based strategies could have investors turning the other away. Instead, investors have been running towards them.

In the high-velocity environment of equities trading, a heavy dose of volatility equates to plenty of opportunities. The capital markets saw exactly that in the first quarter of 2026, which saw strong demand for Direxion Investments' leveraged-inverse ETF product suite.

First-quarter earnings season is accelerating and the automotive euphemism is a good segue into noting that Tesla, Inc. (TSLA) reports results for the first three months of 2026 on Wednesday, April 2022. Tesla said it will release the report after U.S. markets close.